163 related articles for article (PubMed ID: 20696470)
21. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO
Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization, and in vitro evaluation of the starch-based α-amylase responsive hydrogels.
Davoodi-Monfared P; Akbari-Birgani S; Mohammadi S; Kazemi F; Nikfarjam N; Nikbakht M; Mousavi SA
J Cell Physiol; 2021 May; 236(5):4066-4075. PubMed ID: 33151570
[TBL] [Abstract][Full Text] [Related]
23. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
[TBL] [Abstract][Full Text] [Related]
24. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
[TBL] [Abstract][Full Text] [Related]
25. A novel multifunctional NCQDs-based injectable self-crosslinking and in situ forming hydrogel as an innovative stimuli responsive smart drug delivery system for cancer therapy.
Türk S; Altınsoy I; Efe GÇ; Ipek M; Özacar M; Bindal C
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111829. PubMed ID: 33579469
[TBL] [Abstract][Full Text] [Related]
26. Magnetic field-driven drug release from modified iron oxide-integrated polysaccharide hydrogel.
Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W
Int J Biol Macromol; 2018 Mar; 108():558-567. PubMed ID: 29233710
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Injectable Chitosan-based Co-cross-linking Hydrogel for Local Delivery of
Huang FJ; Hung CC; Chang CW; Chao JH; Hsieh BT
Anticancer Res; 2018 Aug; 38(8):4651-4659. PubMed ID: 30061232
[TBL] [Abstract][Full Text] [Related]
29. Genipin-cross-linked poly(L-lysine)-based hydrogels: synthesis, characterization, and drug encapsulation.
Wang SS; Hsieh PL; Chen PS; Chen YT; Jan JS
Colloids Surf B Biointerfaces; 2013 Nov; 111():423-31. PubMed ID: 23872465
[TBL] [Abstract][Full Text] [Related]
30. In vitro cytotoxicity of unsaturated oligo[poly(ethylene glycol) fumarate] macromers and their cross-linked hydrogels.
Shin H; Temenoff JS; Mikos AG
Biomacromolecules; 2003; 4(3):552-60. PubMed ID: 12741769
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery.
Mei L; Xu K; Zhai Z; He S; Zhu T; Zhong W
Org Biomol Chem; 2019 Apr; 17(15):3853-3860. PubMed ID: 30938396
[TBL] [Abstract][Full Text] [Related]
32. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
[TBL] [Abstract][Full Text] [Related]
33. Photo-cross-linked biodegradable hydrogels based on n-arm-poly(ethylene glycol), poly(ε-caprolactone) and/or methacrylic acid for controlled drug release.
Hou P; Zhang N; Wu R; Xu W; Hou Z
J Biomater Appl; 2017 Oct; 32(4):511-523. PubMed ID: 28899224
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
Kaamyabi S; Badrian A; Akbarzadeh A
Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
[TBL] [Abstract][Full Text] [Related]
35. Novel salicylic acid-based chemically crosslinked pH-sensitive hydrogels as potential drug delivery systems.
Demirdirek B; Uhrich KE
Int J Pharm; 2017 Aug; 528(1-2):406-415. PubMed ID: 28559214
[TBL] [Abstract][Full Text] [Related]
36. Injectable and self-healing polysaccharide-based hydrogel for pH-responsive drug release.
Qian C; Zhang T; Gravesande J; Baysah C; Song X; Xing J
Int J Biol Macromol; 2019 Feb; 123():140-148. PubMed ID: 30419332
[TBL] [Abstract][Full Text] [Related]
37. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
38. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer.
Shin H; Jo S; Mikos AG
J Biomed Mater Res; 2002 Aug; 61(2):169-79. PubMed ID: 12061329
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of infection-resistant antibiotics-releasing hydrogels rods of poly[hydroxyethyl methacrylate-co-(poly(ethylene glycol)-methacrylate]: biomedical application in a novel rabbit penile prosthesis model.
Arica MY; Tuğlu D; Başar MM; Kiliç D; Bayramoğlu G; Batislam E
J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):18-28. PubMed ID: 18098187
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
